Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks.
Marco GalluzzoLorenzo MarcelliLaura VellucciClaudia PaganiniVirginia MaffeiLorenzo TofaniAlfredo BelcastroLuca BianchiMarina TalamontiPublished in: Expert opinion on biological therapy (2023)
Real-world data confirm the long-term effectiveness of guselkumab in patients with psoriasis.